Tatiana Viktorovna Kudling (T V Kudling, Tatiana V Kudling, Tatiana Kudling)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Top Venues

Cancer gene therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

Diseases (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Santeri A Pakola, Katriina J Peltola, James H A Clubb, Elise Jirovec, Lyna Haybout, Tatiana Viktorovna Kudling, Tuomo Alanko, Riitta Korpisaari, Susanna M Juteau, Marjut Laukka, Jorma Sormunen, Jukka Kemppainen, Annabrita Hemmes, Teijo Pellinen, Mirte van der Heijden, Dafne C A Quixabeira, Claudia Kistler, Suvi Sorsa, Riikka Havunen, Joao M Santos, Victor Cervera-Carrascon, Akseli E Hemminki
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Santeri A Pakola, Katriina J Peltola, James H A Clubb, Elise Jirovec, Lyna Haybout, Tatiana Viktorovna Kudling, Tuomo Alanko, Riitta Korpisaari, Susanna M Juteau, Marjut Laukka, Jorma Sormunen, Jukka Kemppainen, Annabrita Hemmes, Teijo Pellinen, Mirte van der Heijden, Dafne C A Quixabeira, Claudia Kistler, Suvi Sorsa, Riikka Havunen, Joao M Santos, Victor Cervera-Carrascon, Akseli E Hemminki
Safety, efficacy, and biological data of T cell-enabling oncolytic adenovirus TILT-123 in advanced solid cancers from the TUNIMO monotherapy phase I trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Dafne C A Quixabeira, E Jirovec, Santeri A Pakola, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. Cancer gene therapy (2023)
Dafne C A Quixabeira, Santeri A Pakola, E Jirovec, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Erja Kerkelä, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. Cancer gene therapy (2023)
Dafne C A Quixabeira, Victor Cervera-Carrascon, Joao M Santos, James H A Clubb, Tatiana Viktorovna Kudling, Saru Basnet, Camilla Heiniö, Susanna Grönberg-Vähä-Koskela, Marjukka Anttila, Riikka Havunen, Anna Kanerva, Akseli E Hemminki
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1. Oncoimmunology 11 (1) (2022)
Camilla Heiniö, James Clubb, Tatiana Viktorovna Kudling, Dafne C A Quixabeira, Victor Cervera-Carrascon, Riikka Havunen, Susanna Grönberg-Vähä-Koskela, João Manuel Santos, Johanna Tapper, Anna Kanerva, Akseli E Hemminki
Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers. Diseases (Basel, Switzerland) 10 (3) (2022)
Sadia Zafar, Dafne Carolina Alves Quixabeira, Tatiana Viktorovna Kudling, Victor Cervera-Carrascon, Joao Manuel Santos, Susanna Grönberg-Vähä-Koskela, Fang Zhao, Pasi Aronen, Camilla Heiniö, Riikka Havunen, Suvi Sorsa, Anna Kanerva, Akseli E Hemminki
Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes. Cancer gene therapy 28 (5) (2020)
Alexander V Trofimov, Alexey V Sokolov, Alexandra Y Rak, Alexander M Ischenko, Tatiana Viktorovna Kudling, Andrey V Vakhrushev, Alexei A Gorbunov
Epitope specificity of two anti-morphine monoclonal antibodies: In vitro and in silico studies. Journal of molecular recognition : JMR 33 (9) (2020)